AKT1 and Alzheimer disease: As noted in Table 2, the PI3K-AKT signaling pathway becomes more significantly dysregulated in the network associated with advanced AD and T2D (p = 1.01E-06) compared to the AD–T2D shared network (p = 9.40E-04).